European Journal of Clinical and Experimental Medicine

URI dla tego Zbioruhttp://repozytorium.ur.edu.pl/handle/item/2798

European Journal of Clinical and Experimental Medicine (poprzednio: Przegląd Medyczny Uniwersytetu Rzeszowskiego i Narodowego Instytutu Leków w Warszawie; Medical Review) to recenzowane czasopismo (kwartalnik), wydawane przez Uniwersytet Rzeszowski. Do trzeciego kwartału 2015 roku wersję pierwotną czasopisma stanowiło wydanie papierowe. Od czwartego kwartału 2015 roku wersją pierwotną (referencyjną) czasopisma jest wydanie elektroniczne. European Journal of Clinical and Experimental Medicine jest wydawane w wersji angielskiej. Tematyka prac publikowanych w czasopiśmie obejmuje zagadnienia związane z szeroko pojętą medycyną, medycyną kliniczną, doświadczalną, rehabilitacją, fizjoterapią, farmakoterapią, a także tematy dotyczące oceny jakości leków i bezpieczeństwa ich stosowania. Redakcja publikuje również przedruki (standardy, zalecenia, czy opinie Konsultantów Krajowych różnych dziedzin medycyny) po uprzednim uzyskaniu zgody wydawcy.

Przeglądaj

Aktualnie wyświetlane 1 - 3 z 3

Evaluation of neutrophil phagocytic, complement functions, and cytokines expression among diabetic patients in Abuja, Nigeria
(Wydawnictwo Uniwersytetu Rzeszowskiego, 2019) Babandina, Musa Muhammad; Mainasara, Abdullahi Suleiman; Bakare, Mustapha; Emeribe, Anthony Uchenna; Shuwa, Halima Ali; Haruna, Shamsuddeen; Muhammad, Aminu Said; Abdullahi, Idris Nasir
Introduction. Inflammatory response in Diabetes Mellitus (DM) begins with chronic sub-clinical inflammations as a result of insulin resistance and activation of both innate and adaptive immune system as the disease progresses to complicated diabetes. Hence, the present study investigated the neutrophil phagocytic, complement function (CH50), and some cytokine profiles among diabetic and non-diabetic patients attending the National Hospital in Abuja, Nigeria. Aim. To evaluate the neutrophil phagocytic, complement function (CH50), and some cytokine profiles among post-operative septic diabetic and post-operative septic non-diabetic patients at the National Hospital in Abuja, Nigeria. Material and methods. Subjects were recruited by convenient sampling technique through interviewer-administered questionnaires. Subsequently, blood samples were collected. Fasting blood sugar (FBS) (mmol/L) was determined using glucose oxidase method. Neutrophil function test (Fmol/phag) was assayed using nitroblue tetrazolium reduction test (NBT). Hemolytic complement function (CH 50) test was conducted using serum harvested from sheep sensitized with human group (ORh D +ve) red blood cells. While serum Interleukin-4, -6, -10 and TNF- α were determined using Enzyme Linked Immunosorbent Assay (ELISA). Results. Mean ±} Standard deviation (SD) of FBS concentration of 10.5 ±} 1.3 (mmol/|L) among diabetic and 4.7 ±} 0.9 (mmol/L) among non-diabetics was recorded. There is a decrease in neutrophil phagocytic function with a mean ±} SD of 5.4 ±} 2.1 (Fmol/ phag) in diabetics compared to 9.2 ±} 2.1 (Fmol/phag) in non-diabetics. Similarly, complement (CH 50) function and C-reactive protein were significantly lower in diabetics when compared to non-diabetics (p<0.001). There was a significant difference in IL-6 concentration between diabetics and non-diabetics groups, but no significant difference was observed in TNF-α, IL-4 and IL-10 concentrations between study groups (p>0.05). TNF-α and IL-6 was significantly higher in diabetics with cardiovascular disorders compared to non-diabetics subjects with cardiovascular disorders (p<0.001). Conclusion. Findings from this study revealed the association of complement, neutrophil phagocytic function, CRP and IL-6 among septic diabetic patients,. In addition TNF-α and IL-6 expression was higher in DM patients with cardiovascular disorders.
Seroprevalence of Toxoplasmosis among Human Immunodeficiency Virus infected pregnant women in Abuja Teaching Hospital, Nigeria
(Wydawnictwo Uniwersytetu Rzeszowskiego, 2020) Zakari, Maryam Muhammad; Isah, Aliyu Yabagi; Offiong, Richards; Yunusa, Thairu; Abdullahi, Idris Nasir
Introduction. Toxoplasmosis is a neglected parasitic infection that has economic and epidemiological significance. Data on toxoplasmosis seroprevalence among Human Immunodeficiency Virus (HIV) infected pregnant women may be of obstetric and neonatal concern. Aim. The study was designed to determine the seroprevalence of Toxoplasmosis and associated risk factors in HIV-positive pregnant women attending the University of Abuja Teaching Hospital, Abuja, Northcentral Nigeria. Material and methods. This was a hospital-based cross-sectional study. A total of 160 HIV seropositive pregnant women were recruited. Blood samples were collected and tested for anti-T. gondii IgM and IgG using Enzyme Linked Immunosorbent Assay (ELISA). Structured questionnaires were used to collate the sociodemographic variables of participants. Results. Out of the 160 of HIV seropositive pregnant women, the seroprevalence anti-T. gondii IgG and IgM were 29.4% and 4.4%, respectively. There was no significant association between anti-T. gondii and all sociodemographic variables studied (p>0.05). Conclusion. The overall result of this study revealed that the majority of pregnant women were exposed to toxoplasmosis much earlier in life. Hence, these findings will assist obstetricians and gynecologists in the early diagnosis and management of Toxoplasma gondii infection in pregnant women, especially HIV coinfected ones with IgM seropositivity.
Serosurvey and Cellular Immune Status of HTLV-1/2 and HIV Co-infections in Bauchi State, Nigeria
(Wydawnictwo Uniwersytetu Rzeszowskiego, 2019) Babayo, Adamu; Azeez Akande, Oyebanji; Sabo, Yusuf Mohammed; Abdullahi, Idris Nasir; Dangana, Amos
Introduction. Human T-cell lymphotropic virus types 1 and 2 (HTLV-1 & 2) are frequent co-pathogens among immunosuppressed individuals, particularly HIV/AIDS infected persons. Dual infected persons usually present with false normal or high CD4+ T cells count as a result of the ability of HTLV to induce clonal proliferation of CD4+ T lymphocytes. There is paucity of information on this clinical entity in Nigeria. Aim. This study aimed to determine the seroprevalence of HTLV-1/2 and associated cellular immune response among antiretroviral naďve and experienced HIV infected persons at Bauchi State, Nigeria. Material and methods. One hundred and eighty two (182) HIV seropositive patients’ blood samples were analyzed for anti HTLV-1/2 IgM and IgG antibodies using ELISA while CD4+ T cells were counted using Flow cytometry technique. Socio-demographic data of the subjects and clinical history were obtained via questionnaire and medical records, respectively. Results. The seroprevalence of anti-HTLV-1/2 was 14%. This comprised 76 (41.8%) males and 106 (58.2%) females. Six (3%) were seropositive for both ant-HTLV -1&2 IgM and IgG. Of the total positive for anti-HTLV-1/2, 20 (25%) ART-naďve and 6(5.9%) ART-experience subjects. Whole blood CD4+ T cell count was significantly high in HTLV-1/-2 IgG/IgM seropositive subjects compared to their HTLV-1/-2 negative counterpart. Conclusion. All subjects (100%) who were HTLV-1/-2/HIV co-infected had normal to higher CD4+ T cell counts. It is suggested to be very careful in using only CD4+ counts to monitor HIV progression or as indicators for ART.

Przeglądaj

Przeglądanie European Journal of Clinical and Experimental Medicine według Autor "Abdullahi, Idris Nasir"